Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / [email protected] ICP License: 琼ICP备2022009338号
TechFlow news, July 8 — According to CoinDesk, brokerage firm Benchmark has assigned Semler Scientific a "buy" rating with a target stock price of $101. Analyst Mark Palmer expressed optimism about the company's strategic shift from medical diagnostics to bitcoin reserves. The company has acquired approximately 4,636 bitcoins for $430 million, at an average cost basis of $92,753 per bitcoin.
According to CoinDesk, brokerage Benchmark has given Semler Scientific a "buy" rating and set its stock price target at $101. Analyst Mark Palmer expressed optimism about the company's transition from the medical diagnostics sector to a Bitcoin reserve strategy. The company has acquired approximately 4,636 bitcoins for $430 million, with an average cost basis of $92,753 per bitcoin.
Navigating Web3 tides with focused insights
